EGFR、MTDH、ERCC1在口腔特殊亚型的鳞状细胞癌中的表达及临床意义

doi:10.13701/j.cnki.kqyxyj.2018.06.012

口腔医学研究 ›› 2018, Vol. 34 ›› Issue (6): 623-626.DOI: 10.13701/j.cnki.kqyxyj.2018.06.012

EGFR、MTDH、ERCC1在口腔特殊亚型的鳞状细胞癌中的表达及临床意义

陈蔚华^*, 裴婧, 贾云香

南昌大学附属口腔医院病理科,江西省口腔生物医学重点实验室江西南昌 330006

收稿日期:2017-12-21 出版日期:2018-06-20 发布日期:2018-06-21
通讯作者: 陈蔚华,电话:0791—86360643
作者简介:陈蔚华(1968~ )女,浙江余姚人,硕士,副主任医师,主要从事口腔颌面部肿瘤和口腔黏膜病的病理研究。
基金资助:
江西省科技厅社会发展科技支撑项目(编号:20111BBG70027-5)

Expression and Clinical Significance of EGFR, MTDH, and ERCC1 in Special Subtypes of Oral Squamous Carcinoma

CHEN Wei-hua^*, PEI Jing, JIA Yun-xiang

Department of Pathology, Affiliated Stomatological Hospital of Nanchang University, The Key Laboratory of Oral Biomedicine of Jiangxi Province, Nanchang 330006, China

Received:2017-12-21 Online:2018-06-20 Published:2018-06-21

摘要/Abstract

摘要： 目的:探讨EGFR、MTDH、ERCC1在口腔特殊亚型的鳞状细胞癌(简称鳞癌)中的表达意义,为其治疗提供依据。方法:运用免疫组化二步法检测口腔特殊亚型鳞状细胞癌的EGFR、MTDH、ERCC1的表达情况。结果:口腔腺鳞癌比基底样鳞癌、乳头状鳞癌和梭形细胞癌中的EGFR表达高,后三者又比疣状癌的表达高(P＜0.05);腺鳞癌比基底样鳞癌、乳头状鳞癌和疣状癌中的MTDH、ERCC1表达高,后三者又比梭形细胞癌的表达高(P＜0.05);腺鳞癌比基底样鳞癌的淋巴结转移率高,基底样鳞癌比乳头状鳞癌、梭形细胞癌和疣状癌的淋巴结转移率高(P＜0.05)。结论:EGFR、MTDH和ERCC1的表达水平可以作为评估口腔特殊亚型鳞状细胞癌种类的重要生物学指标,为口腔特殊亚型鳞状细胞癌治疗提供基础与依据。

关键词: 口腔鳞状细胞癌, 特殊亚型, ERCC1, MTDH, EGFR

Abstract: Objective: To explore the expression of EGFR, MTDH, and ERCC1 in special subtypes of oral squamous cell carcinoma. Methods: Immunohistochemistry polymer was applied to detect special subtypes of oral squamous cell carcinoma. Results: The expression of EGFR in oral adenosquamous carcinoma was higher than that of basaloid squamous cell carcinoma, papillary squamous cell carcinoma, and spindle cell carcinoma, and the expression in verrucous carcinoma was the weakest(P＜0.05). The expressions of MTDH and ERCC1 in oral adenosquamous carcinoma were higher than those of basaloid squamous cell carcinoma, papillary squamous cell carcinoma, and verrucous carcinoma, and the expressions in spindle cell carcinoma was the weakest(P＜0.05). The metastasis rate of lymph nodes in oral adenosquamous carcinoma was higher than that of basaloid squamous cell carcinoma, and the rates in papillary squamous cell carcinoma, spindle cell carcinoma, and verrucous carcinoma were weaker(P＜0.05). Conclusion: The levels of EGFR, MTDH, and ERCC1 can be used as important biomarkers for evaluation,which may provide the basis for the treatments of special subtypes of oral squamous cell carcinoma.

Key words: Oral squamous carcinoma, Special subtypes, EGFR, MTDH, ERCC1

陈蔚华, 裴婧, 贾云香. EGFR、MTDH、ERCC1在口腔特殊亚型的鳞状细胞癌中的表达及临床意义[J]. 口腔医学研究, 2018, 34(6): 623-626.

CHEN Wei-hua, PEI Jing, JIA Yun-xiang. Expression and Clinical Significance of EGFR, MTDH, and ERCC1 in Special Subtypes of Oral Squamous Carcinoma[J]. Journal of Oral Science Research, 2018, 34(6): 623-626.

参考文献

[1] Moghtadaei M, Hashemi Golpayegani MR, et al. Predicting the risk of squamous dysplasia and esophageal squamous cell carcinoma using minimum classification error method [J]. Comput Biol Med,2014,45:51-57
[2] 马捷,刘莹,朱东旺,等.EGFR在局部晚期口腔鳞癌中的表达与TPF诱导化疗的关系[J].中国口腔颌面外科杂志,2013,11(3):209-214
[3] 周志毅,杨国仪,孙荣超,等.非小细胞肺癌中MTDH及VEGF表达的临床病理意义[J].临床与实验病理学杂志,2011,27(12):1294-1296
[4] 何黎明,郭新程,陶山松,等.CCND1、ORAOV1、ERCC1在舌鳞状细胞癌中的表达和临床意义[J].口腔医学研究,2015,31(6):597-600
[5] Su NW, Leu YS, Lee JC, et al. EGF and EGFR genetic polymorphisms predict prognosis in locally advanced pharyngolaryngeal squamous cell carcinoma patients receiving postoperative concurrent chemoradiotherapy [J]. Onco Targets Ther, 2014, 7:2197-2204
[6] Price KA, Cohen EE. Mechanisms of and therapeutic approaches for overcoming resistance to epidermal growth factor(EGFR)-targeted therapy in squamous cell carcinoma of the head and neck(SCCHN) [J]. Oral Oncol, 2015,51(5):399-408
[7] Cohen RB. Current challenges and clinical investigations of epidermal growth factor receptor(EGFR)- and ErbB family-targeted agents in the treatment of head and neck squamous cell carcinoma(HNSCC) [J]. Cancer Treat Rev, 2014, 40(4):567-577
[8] Benhabbour SR, Luft JC, Kim D, et al. In vitro and in vivo assessment of targeting lipid-based nanoparticles to the epidermal growth factor-receptor (EGFR) using a novel Heptameric Z ~(EGFR) domain [J]. J Control Release,2012,158(1):63-71
[9] Sarkar D, Fisher PB.AEG-1/MTDH/LYRIC: clinical significance [J]. Adv Cancer Res,2013,120:39-74
[10] Xia X, Du R, Zhao L. Expression of AEG-1 and microvessel density correlates with metastasis and prognosis of oral squamous carcinoma [J]. Hum Pathol,2014, 45(4):858-865
[11] 邓年丰,冯云枝.舌鳞状细胞癌组织中EphA7和MTDH表达及其临床病理意义[J].中南大学学报(医学版),2011,36(12):1195-1198
[12] Gao Y, Liu D. The roles of excision repair cross-complementation group1 in objective response after cisplatin-based concurrent chemoradiotherapy and survival in head and neck cancers: A systematic review and meta-analysis [J]. Oral Oncol,2015,51(6):570-577
[13] Chiu TJ, Chen CH, Chien CY, et al. High ERCC1 expression predicts cisplatin-based chemotherapy resistance and poor outcome in unresectable squamous cell carcinoma of head and neck in a betel-chewing area [J]. J Transl Med, 2011, 9(1):31
[14] 王君芳,王巍,李晓刚,等.口腔鳞癌细胞EGFR的表达与顺铂敏感性关系的研究[J].口腔颌面外科杂志,2011,21(5):318-321
[15] 王启明,谢晓冬.MTDH与肿瘤关系的研究进展[J].中华肿瘤防治杂志,2011,18(14):1138-1140

EGFR、MTDH、ERCC1在口腔特殊亚型的鳞状细胞癌中的表达及临床意义

Expression and Clinical Significance of EGFR, MTDH, and ERCC1 in Special Subtypes of Oral Squamous Carcinoma

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	高安天, 林梓桐. 口腔鳞状细胞癌边界精准评价的光学成像研究进展[J]. 口腔医学研究, 2020, 36(5): 413-415.
[2]	杨凯成, 杨蕾, 赵建广, 罗风玉, 陈彦平, 崔子峰, 陈赫, 满莎莎. 口腔鳞状细胞癌患者外周血microRNA的表达及预后意义[J]. 口腔医学研究, 2020, 36(5): 428-432.
[3]	胡勤刚, 赵星星. 口腔鳞状细胞癌肿瘤相关成纤维细胞的研究进展[J]. 口腔医学研究, 2020, 36(4): 309-313.
[4]	郭俊峰, 张纲, 谭颖徽. CYP27B1在口腔鳞状细胞癌中的表达及其与预后的关系[J]. 口腔医学研究, 2020, 36(10): 930-933.
[5]	谢龙, 桑磊, 宋卓英, 江燕军. 唾液中微小RNA-375对口腔鳞状细胞癌的诊断价值及其对人口腔鳞状细胞癌细胞生物学功能的影响[J]. 口腔医学研究, 2019, 35(9): 883-888.
[6]	高旭,周阳,李琛,薛晓寒,魏秀峰. Eya4在口腔鳞状细胞癌中的表达及其意义[J]. 口腔医学研究, 2019, 35(6): 555-558.
[7]	周童,张桐菲,张泽兵,全海英. 甲基硒酸对口腔癌细胞增殖、迁移、凋亡和周期的作用研究[J]. 口腔医学研究, 2019, 35(6): 568-572.
[8]	熊璟,何元春,刘杰,张英,李永强,邱勇棋,庄瑞. 白藜芦醇通过调控雷帕霉素靶蛋白/M2型丙酮酸激酶轴抑制口腔鳞状细胞癌细胞的糖酵解作用[J]. 口腔医学研究, 2019, 35(6): 573-576.
[9]	陆展翼, 胡勤刚, 陈盛, 杨艳, 丁亮, 泥艳红. 口腔鳞状细胞癌组织TGF-β1表达和临床病理学参数对预后的影响[J]. 口腔医学研究, 2019, 35(5): 433-438.
[10]	刘艳玲, 赵曦, 余丽, 聂敏海. SOX-9在口腔鳞状细胞癌组织中的表达及其临床意义[J]. 口腔医学研究, 2019, 35(5): 439-442.
[11]	白真玉, 王铠, 刘德裕, 黄谢山. 长链非编码RNA FAL1在口腔鳞状细胞癌中的表达及其与预后的关系[J]. 口腔医学研究, 2019, 35(4): 360-363.
[12]	王晓乐, 贾荣. 口腔鳞状细胞癌患者年龄分布与肿瘤分子标记物的关系研究[J]. 口腔医学研究, 2019, 35(3): 238-241.
[13]	伍俊锋, 施斌, 曹裕杰, 陈法, 曹熔锴, 张诗蕾, 黄跃. 福建地区老年口腔鳞状细胞癌预后影响因素研究[J]. 口腔医学研究, 2019, 35(3): 242-245.
[14]	李勇伟,邱勋定,顾明,邓旎,谢莉莉. 同源形成素样蛋白2基因对口腔鳞状细胞癌侵袭、迁移及核因子-κB信号的影响[J]. 口腔医学研究, 2019, 35(2): 137-141.
[15]	孙志军, 武磊. 口腔鳞状细胞癌免疫检查点的研究进展[J]. 口腔医学研究, 2019, 35(12): 1107-1110.